Clinical trial
Biological Effect of Warfarin on Pancreatic Cancer
NCT03536208 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Biological Effect of Warfarin on Pancreatic Cancer
- Lead sponsor
- University of Texas Southwestern Medical Center
- Phase
- Phase 1
- Overall status
- Withdrawn
- Start date
- May 15, 2019
- Completion date
- June 30, 2022
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pancreatic cancer